These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 14769834

  • 1. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 2. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A, Murata S, Nishio A.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [Abstract] [Full Text] [Related]

  • 3. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 4. Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.
    Anastasopoulos F, Leung R, Kladis A, James GM, Briscoe TA, Gorski TP, Campbell DJ.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):799-805. PubMed ID: 9495836
    [Abstract] [Full Text] [Related]

  • 5. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of vasopeptidase inhibitor-induced plasma extravasation: comparison of omapatrilat and the novel neutral endopeptidase 24.11/angiotensin-converting enzyme inhibitor GW796406.
    Sulpizio AC, Pullen MA, Edwards RM, Louttit JB, West R, Brooks DP.
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1306-13. PubMed ID: 16144980
    [Abstract] [Full Text] [Related]

  • 7. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
    Dusser DJ, Nadel JA, Sekizawa K, Graf PD, Borson DB.
    J Pharmacol Exp Ther; 1988 Feb; 244(2):531-6. PubMed ID: 3279179
    [Abstract] [Full Text] [Related]

  • 8. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
    Seccia TM, Belloni AS, Guidolin D, Sticchi D, Nussdorfer GG, Pessina AC, Rossi GP.
    J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
    [Abstract] [Full Text] [Related]

  • 9. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
    Arbin V, Claperon N, Fournié-Zaluski MC, Roques BP, Peyroux J.
    Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
    [Abstract] [Full Text] [Related]

  • 10. Effect of quercetin on plasma extravasation in rat CNS and dura mater by ACE and NEP inhibition.
    Cyrino LA, Cardoso RC, Hackl LP, Nicolau M.
    Phytother Res; 2002 Sep; 16(6):545-9. PubMed ID: 12237812
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a dual inhibitor of angiotensin I-converting enzyme and neutral endopeptidase.
    French JF, Flynn GA, Giroux EL, Mehdi S, Anderson B, Beach DC, Koehl JR, Dage RC.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):180-6. PubMed ID: 8301555
    [Abstract] [Full Text] [Related]

  • 12. Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
    Dalzell JR, Seed A, Berry C, Whelan CJ, Petrie MC, Padmanabhan N, Clarke A, Biggerstaff F, Hillier C, McMurray JJ.
    Cardiovasc Ther; 2014 Feb; 32(1):13-8. PubMed ID: 24138103
    [Abstract] [Full Text] [Related]

  • 13. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V, Claperon N, Fournié-Zaluski MC, Roques BP, Peyroux J.
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [Abstract] [Full Text] [Related]

  • 14. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 15. Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.
    Pelorosso FG, Halperin AV, Palma AM, Nowak W, Errasti AE, Rothlin RP.
    J Pharmacol Exp Ther; 2007 Feb; 320(2):713-20. PubMed ID: 17085545
    [Abstract] [Full Text] [Related]

  • 16. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG, Yu C, Renner T, Thibodeaux H, Armstrong SR, Park T, Cheruvu M, Olsufka R, Sandvik ER, Lane CE, Budman J, Hill CM, Klein U, Hegde SS.
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [Abstract] [Full Text] [Related]

  • 17. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA, Marchini F, Morazzoni G, Vegh A, Papp JG, Parratt JR.
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [Abstract] [Full Text] [Related]

  • 18. Neurogenic plasma extravasation in the rat nasal mucosa is potentiated by peptidase inhibitors.
    Petersson G, Bacci E, McDonald DM, Nadel JA.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):509-14. PubMed ID: 8423549
    [Abstract] [Full Text] [Related]

  • 19. Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat.
    Kubota E, Dean RG, Hubner RA, Casley DJ, Johnston CI, Burrell LM.
    Clin Sci (Lond); 2003 Sep; 105(3):339-45. PubMed ID: 12741953
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.